Juno jumps on cancer therapy wave
But the journey to commercialising the bespoke medication remains daunting
Minneapolis
IT'S a cancer therapy straight out of Greek mythology, bespoke medicine with astonishing results in the smallest and sickest of patients.
The treatment, called a chimeric antigen receptor, or CAR for short, has captured the attention of the biggest drug companies and become a hotbed for biotechnology startups. A medical amalgam like the chimera in Homer's Iliad - a fire- breathing monster with a lion's head, a goat's body and a snake's tail - it may offer the best chance for patients like toddler Greta Oberhofer to beat acute lymphoblastic leukemia.
Copyright SPH Media. All rights reserved.